Medline seeks to raise up to $7bn in 2025’s biggest Wall Street IPO
Upsized deal to test investor appetite for new listings at end of choppy year
Related reading
Medline readies IPO in coming months in test of investor appetite
Offering seen as signal of whether large private equity groups can begin exiting largest deals
European IPO market starts 2026 at record pace, sparking hope of revival
Investment bankers embrace ‘intense’ pitching as groups in defence, tech and wider economy prepare to go public
Looming listings put ailing European IPO market to test
Bankers and lawyers cautiously optimistic that investor confidence is returning
There is method in the market’s madness
But it relies on a host of rosy assumptions going in investors’ favour
Making IPOs great again has its pitfalls
The US needs more public listings but the regulatory pendulum may be swinging too far
Meta’s record sales boost shares 10% despite massive spending plans
Strong earnings appear to quiet demands from Wall Street to justify up to $135bn in capital expenditures